医疗保险对颈动脉支架置入术的报销范围应扩大到患有颈动脉狭窄的标准风险和低风险有症状及无症状患者吗？ - Suppr | 超能文献

Should Medicare reimbursement for carotid artery stenting be extended to standard and low risk symptomatic and asymptomatic patients with carotid stenosis?

作者信息

Gray William A, Macdonald Sumaira, Schneider Peter A

机构信息

Columbia University College of Physicians and Surgeons, New York, NY, USA.

出版信息

Vascular. 2012 Feb;20(1):7-11. doi: 10.1258/vasc.2011.201103. Epub 2012 Jan 25.

DOI:10.1258/vasc.2011.201103

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Should Medicare reimbursement for carotid artery stenting be extended to standard and low risk symptomatic and asymptomatic patients with carotid stenosis?医疗保险对颈动脉支架置入术的报销范围应扩大到患有颈动脉狭窄的标准风险和低风险有症状及无症状患者吗？

Vascular. 2012 Feb;20(1):7-11. doi: 10.1258/vasc.2011.201103. Epub 2012 Jan 25.

2

Why the United States Center for Medicare and Medicaid Services should not extend reimbursement indications for carotid artery angioplasty/stenting.为何美国医疗保险和医疗补助服务中心不应扩大颈动脉血管成形术/支架置入术的报销适应症。

Vascular. 2012 Feb;20(1):1-7. doi: 10.1258/vasc.2011.201102. Epub 2012 Jan 23.

3

CMS considers expanding reimbursement for carotid stenting.美国医疗保险和医疗补助服务中心考虑扩大对颈动脉支架置入术的报销范围。

Vascular. 2012 Feb;20(1):1. doi: 10.1258/vasc.2011.201104. Epub 2012 Jan 25.

4

Let my people (Medicare patients) go: a plea to the centers of Medicare and Medicaid services.

Catheter Cardiovasc Interv. 2010 Apr 1;75(5):656-7. doi: 10.1002/ccd.22521.

5

Why the United States Center for Medicare and Medicaid Services (CMS) should not extend reimbursement indications for carotid artery angioplasty/stenting.为何美国医疗保险和医疗补助服务中心（CMS）不应扩大颈动脉血管成形术/支架置入术的报销指征。

Int Angiol. 2012 Feb;31(1):85-9.

6

Carotid endarterectomy: still the standard of care for carotid bifurcation disease.颈动脉内膜切除术：仍是颈动脉分叉病变的标准治疗方法。

Semin Vasc Surg. 2011 Mar;24(1):10-20. doi: 10.1053/j.semvascsurg.2011.03.005.

7

Catch-22: Carotid stenting is safe and effective (Food and Drug Administration) but is it reasonable and necessary (Centers for Medicare and Medicaid Services)?第二十二条军规：颈动脉支架置入术是安全有效的（美国食品药品监督管理局），但它合理且必要吗？（美国医疗保险和医疗补助服务中心）

JACC Cardiovasc Interv. 2012 Jun;5(6):694-6. doi: 10.1016/j.jcin.2012.05.001.

8

Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial.增加手术风险患者颈动脉支架置入术与内膜切除术的成本和成本效益：来自 SAPPHIRE 试验的结果。

Catheter Cardiovasc Interv. 2011 Mar 1;77(4):463-72. doi: 10.1002/ccd.22869.

9

Economics of carotid revascularization.颈动脉血运重建的经济学

Catheter Cardiovasc Interv. 2011 Mar 1;77(4):473-4. doi: 10.1002/ccd.23001.

10

Cost implications of more widespread carotid artery stenting consistent with the American College of Cardiology/American Heart Association guideline.更广泛地采用符合美国心脏病学会/美国心脏协会指南的颈动脉支架置入术的成本影响。

J Vasc Surg. 2012 Feb;55(2):585-7. doi: 10.1016/j.jvs.2011.10.034. Epub 2011 Dec 20.

引用本文的文献

1

Unplanned readmission after carotid stenting versus endarterectomy: analysis of the United States Nationwide Readmissions Database.颈动脉支架置入术与颈动脉内膜切除术治疗后非计划性再入院的比较：美国全国再入院数据库分析。

J Neurointerv Surg. 2023 Mar;15(3):242-247. doi: 10.1136/neurintsurg-2021-018523. Epub 2022 Feb 15.

2

Asymptomatic carotid stenosis: immediate revascularization or watchful waiting?无症状颈动脉狭窄：立即血运重建还是静观其变？

Curr Cardiol Rep. 2014 Jan;16(1):440. doi: 10.1007/s11886-013-0440-9.